Myriad Genetics, Inc. (NASDAQ:MYGN) Investor Notice: Investigation over Potential Wrongdoing

San Diego, CA -- (SBWIRE) -- 01/25/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Myriad Genetics, Inc.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.